New national survey finds consumers overwhelmingly want FDA approval — but only 17% know compounded GLP-1 products are not approved

WASHINGTON, July 14, 2026 /PRNewswire/ -- Americans for Safe and Effective Medicines (ASEM) today launched as a new national advocacy organization dedicated to protecting patients from illegal mass compounding, counterfeit products, and misleading marketing practices and holding bad actors accountable. The organization's launch comes as its inaugural survey reveals a significant gap: 84 percent of consumers want Food & Drug Administration (FDA) approval of their GLP-1 medications but only 17 percent know that compounded GLP-1 products are not FDA approved.